Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)

Ashish Sharma*, Peter K. Kaiser, Ramin Tadayoni, Frank G. Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D. Regillo, Kourous A. Rezaei, Arshad M. Khanani, Francesco Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Ram Dogra, Muralidhar NSManisha Agarwal, Anat Loewenstein, Baruch D. Kuppermann, Giuseppe Querques, Jay Sheth, Seemantini Ayachit, Chitaranjan Mishra, Debdulal Chakraborty, Alay Banker, Şengül Özdek, Kodjikian Laurent, Alper Bilgic, Paolo Lanzetta, Caroline Baumal, Nancy Holekemp, Taiji Sakamoto, Adnan Tufail, Nicolas Yannuzzi, Giulia Corradetti, David Boyer, Aleksandra Rachitskaya, Tunde Peto, Maximilian W.M. Wintergerst, Valentina Sarao, Barbara Parolini, Prithvi Mruthyunjaya, Quan Dong Nguyen, Diana V. Do, Pearse A. Keane, Tarek Hassan, International Retina Biosimilar Study Group (Inter BIOS Group)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3392-3395
JournalEye (Basingstoke)
Volume38
Early online date26 Aug 2024
DOIs
Publication statusPublished - Dec 2024

Keywords

  • anti-VEGF biosimilars
  • retinal diseases
  • vitreo-retinal
  • India

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this